Cargando…

Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial

INTRODUCTION: Intensive insulin treatment of critically ill patients was seen as a promising method of treatment, though recent studies showed that reducing the blood glucose level below 6 mmol/l had a detrimental outcome. The mechanisms of the effects of insulin in the critically ill are not comple...

Descripción completa

Detalles Bibliográficos
Autores principales: Žuran, Ivan, Poredoš, Pavel, Skale, Rafael, Voga, Gorazd, Gabršček, Lucija, Parežnik, Roman
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811932/
https://www.ncbi.nlm.nih.gov/pubmed/20003200
http://dx.doi.org/10.1186/cc8202
_version_ 1782176814371700736
author Žuran, Ivan
Poredoš, Pavel
Skale, Rafael
Voga, Gorazd
Gabršček, Lucija
Parežnik, Roman
author_facet Žuran, Ivan
Poredoš, Pavel
Skale, Rafael
Voga, Gorazd
Gabršček, Lucija
Parežnik, Roman
author_sort Žuran, Ivan
collection PubMed
description INTRODUCTION: Intensive insulin treatment of critically ill patients was seen as a promising method of treatment, though recent studies showed that reducing the blood glucose level below 6 mmol/l had a detrimental outcome. The mechanisms of the effects of insulin in the critically ill are not completely understood. The purpose of the study was to test the hypothesis that intensive insulin treatment may influence forearm blood flow independently of global hemodynamic indicators. METHODS: The study encompassed 29 patients of both sexes who were admitted to the intensive care unit due to sepsis and required artificial ventilation as the result of acute respiratory failure. 14 patients were randomly selected for intensive insulin treatment (Group 1; blood glucose concentration 4.4-6.1 mmol/l), and 15 were selected for conventional insulin treatment (Group 2; blood glucose level 7.0 mmol/l-11.0 mmol/l). At the start of the study (t(0), beginning up to 48 hours after admittance and the commencement of artificial ventilation), at 2 hours (t(1)), 24 hours (t(2)), and 72 hours (t(3)) flow in the forearm was measured for 60 minutes using the strain-gauge plethysmography method. Student's t-test of independent samples was used for comparisons between the two groups, and Mann-Whitney's U-test where appropriate. Linear regression analysis and the Pearson correlation coefficient were used to determine the levels of correlation. RESULTS: The difference in 60-minute forearm flow at the start of the study (t(0)) was not statistically significant between groups, while at t(2 )and t(3 )significantly higher values were recorded in Group 1 (t(2); Group 1: 420.6 ± 188.8 ml/100 ml tissue; Group 2: 266.1 ± 122.2 ml/100 ml tissue (95% CI 30.9-278.0, P = 0.02); t(3); Group 1: 369.9 ± 150.3 ml/100 ml tissue; Group 2: 272.6 ± 85.7 ml/100 ml tissue (95% CI 5.4-190.0, P = 0.04). At t(1 )a trend towards significantly higher values in Group 1 was noted (P = 0.05). The level of forearm flow was related to the amount of insulin infusion (r = 0.40). CONCLUSIONS: Compared to standard treatment, intensive insulin treatment of critically ill patients increases forearm flow. Flow increase was weakly related to the insulin dose, though not to blood glucose concentration. TRIAL REGISTRATION: Trial number: ISRCTN39026810.
format Text
id pubmed-2811932
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28119322010-01-28 Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial Žuran, Ivan Poredoš, Pavel Skale, Rafael Voga, Gorazd Gabršček, Lucija Parežnik, Roman Crit Care Research INTRODUCTION: Intensive insulin treatment of critically ill patients was seen as a promising method of treatment, though recent studies showed that reducing the blood glucose level below 6 mmol/l had a detrimental outcome. The mechanisms of the effects of insulin in the critically ill are not completely understood. The purpose of the study was to test the hypothesis that intensive insulin treatment may influence forearm blood flow independently of global hemodynamic indicators. METHODS: The study encompassed 29 patients of both sexes who were admitted to the intensive care unit due to sepsis and required artificial ventilation as the result of acute respiratory failure. 14 patients were randomly selected for intensive insulin treatment (Group 1; blood glucose concentration 4.4-6.1 mmol/l), and 15 were selected for conventional insulin treatment (Group 2; blood glucose level 7.0 mmol/l-11.0 mmol/l). At the start of the study (t(0), beginning up to 48 hours after admittance and the commencement of artificial ventilation), at 2 hours (t(1)), 24 hours (t(2)), and 72 hours (t(3)) flow in the forearm was measured for 60 minutes using the strain-gauge plethysmography method. Student's t-test of independent samples was used for comparisons between the two groups, and Mann-Whitney's U-test where appropriate. Linear regression analysis and the Pearson correlation coefficient were used to determine the levels of correlation. RESULTS: The difference in 60-minute forearm flow at the start of the study (t(0)) was not statistically significant between groups, while at t(2 )and t(3 )significantly higher values were recorded in Group 1 (t(2); Group 1: 420.6 ± 188.8 ml/100 ml tissue; Group 2: 266.1 ± 122.2 ml/100 ml tissue (95% CI 30.9-278.0, P = 0.02); t(3); Group 1: 369.9 ± 150.3 ml/100 ml tissue; Group 2: 272.6 ± 85.7 ml/100 ml tissue (95% CI 5.4-190.0, P = 0.04). At t(1 )a trend towards significantly higher values in Group 1 was noted (P = 0.05). The level of forearm flow was related to the amount of insulin infusion (r = 0.40). CONCLUSIONS: Compared to standard treatment, intensive insulin treatment of critically ill patients increases forearm flow. Flow increase was weakly related to the insulin dose, though not to blood glucose concentration. TRIAL REGISTRATION: Trial number: ISRCTN39026810. BioMed Central 2009 2009-12-09 /pmc/articles/PMC2811932/ /pubmed/20003200 http://dx.doi.org/10.1186/cc8202 Text en Copyright ©2009 Žuran et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Žuran, Ivan
Poredoš, Pavel
Skale, Rafael
Voga, Gorazd
Gabršček, Lucija
Parežnik, Roman
Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
title Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
title_full Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
title_fullStr Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
title_full_unstemmed Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
title_short Intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
title_sort intensive insulin treatment improves forearm blood flow in critically ill patients: a randomized parallel design clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811932/
https://www.ncbi.nlm.nih.gov/pubmed/20003200
http://dx.doi.org/10.1186/cc8202
work_keys_str_mv AT zuranivan intensiveinsulintreatmentimprovesforearmbloodflowincriticallyillpatientsarandomizedparalleldesignclinicaltrial
AT poredospavel intensiveinsulintreatmentimprovesforearmbloodflowincriticallyillpatientsarandomizedparalleldesignclinicaltrial
AT skalerafael intensiveinsulintreatmentimprovesforearmbloodflowincriticallyillpatientsarandomizedparalleldesignclinicaltrial
AT vogagorazd intensiveinsulintreatmentimprovesforearmbloodflowincriticallyillpatientsarandomizedparalleldesignclinicaltrial
AT gabrsceklucija intensiveinsulintreatmentimprovesforearmbloodflowincriticallyillpatientsarandomizedparalleldesignclinicaltrial
AT pareznikroman intensiveinsulintreatmentimprovesforearmbloodflowincriticallyillpatientsarandomizedparalleldesignclinicaltrial